Back to BARCLAYS PLC BARCLAYS PLC

MCRBMCRB

Showing 4 of 27 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in SERES THERAPEUTICS INC

As of its Q1 2025 13F, Barclays held 1,593 shares of MCRB (Seres Therapeutics), worth $1,115. Barclays' 13F filings listed MCRB from Q4 2018 to Q1 2025, 26 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1,509

Total Shares Change

-1,595

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$9.10
0
2025-Q1
Decreased
1,593
-0.1%
$1,1150.0%$14.42
0
2024-Q4
Unchanged
1,595
0.0%
$1,3250.0%$16.62
0
2024-Q3
Decreased
1,595
-22.2%
$1,5090.0%$18.38
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used